07/09/2026
This Urology Awareness Month, we're highlighting a major breakthrough in prostate cancer treatment.
A major new study led by researchers at Imperial College London and Imperial College Healthcare NHS Trust has found that focal therapy for prostate cancer is just as effective as surgery or radiotherapy, with a lower risk of side effects.
Supported by National Institute for Health and Care Research, the 10-year study is the largest of its kind, involving 3,477 men across 14 hospitals in the UK. The findings provide important evidence to support the wider use of focal therapy, helping more men access effective treatment with improved quality of life.
Focal therapy is a targeted treatment that destroys cancer cells within the prostate using carefully directed energy, such as heat, cold or electrical pulses, while preserving as much healthy tissue as possible.
Unlike surgery or radiotherapy, focal therapy offers faster recovery and better preservation of urinary and sexual function, helping patients return to everyday life sooner with fewer side effects.
At Imperial College Healthcare Private Care, we offer three types of focal therapy:
• HIFU (high-intensity focused ultrasound)
• Cryotherapy
• NanoKnife electroporation
Each treatment is tailored to the size and location of a patient's cancer and delivered by our expert team led by Mr Taimur Shah, clinical associate professor and consultant urologist and senior co-author of the study.
As we mark Urology Awareness Month, we're proud to offer this pioneering, less invasive treatment option for men with prostate cancer and to support advances that improve outcomes and quality of life. Find out more via link in bio.